TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35704394

Group type: COMPARATOR
Intervention: OnabotulinumtoxinA 20 U
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 40 U
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 60 U
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA 80 U
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (all higher doses)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Facial Line Satisfaction Questionnaire
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Treatment-emergent adverse events
Number of subjects: 226
Study: 34129025

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 773

Group type: COMPARATOR
Intervention: Landmark models using current PSA alone
Number of subjects: 773

Group type: COMPARATOR
Intervention: Joint models with linear vs nonlinear PSA
Number of subjects: 773
Study: 32859388

Group type: EXPERIMENTAL
Intervention: CD144 expression
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Borrmann type and CD144 expression
Number of subjects: 173
Study: 35773804

Group type: EXPERIMENTAL
Intervention: Smartphone-based digital game during the course
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional instructional activities
Number of subjects: 60
Study: 34596556

Group type: EXPERIMENTAL
Intervention: Novel distributed primal‐dual fixed point algorithm based on an adapted metric method.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized asynchronous iterative distributed algorithm with randomized coordinate activation mechanism.
Number of subjects: 0
Study: 32594915

Group type: EXPERIMENTAL
Intervention: Purple Wheat (PW)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Regular Wheat (RW)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Comparison between PW and RW
Number of subjects: 29
Study: 35271478

Group type: EXPERIMENTAL
Intervention: Enteral lactoferrin supplementation (100 mg/day until PMA of 36 weeks or discharge)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 117
Study: 34173129

Group type: EXPERIMENTAL
Intervention: Oral octreotide capsules (OOC) in CH‐ACM‐01 trial
Number of subjects: 211

Group type: COMPARATOR
Intervention: Oral octreotide capsules (OOC) in CHIASMA OPTIMAL trial
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Oral octreotide capsules (OOC) in both trials
Number of subjects: 211
Study: 35131832

Group type: EXPERIMENTAL
Intervention: No/Partial Smoke-Free Home Restrictions (SFH) among non-smokers in Armenia
Number of subjects: 1456

Group type: EXPERIMENTAL
Intervention: No/Partial Smoke-Free Home Restrictions (SFH) among smokers in Armenia
Number of subjects: 1456

Group type: EXPERIMENTAL
Intervention: No/Partial Smoke-Free Home Restrictions (SFH) among non-smokers in Georgia
Number of subjects: 1456

Group type: EXPERIMENTAL
Intervention: No/Partial Smoke-Free Home Restrictions (SFH) among smokers in Georgia
Number of subjects: 1456
Study: 33155461

Group type: EXPERIMENTAL
Intervention: IV acetaminophen and IM pethidine (Group A)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: IV acetaminophen and IV parecoxib (Group B)
Number of subjects: 316

Group type: COMPARATOR
Intervention: IV acetaminophen monotherapy (Group C)
Number of subjects: 316
Study: 32061444

Group type: EXPERIMENTAL
Intervention: Single-step characterization (SC) with one firing cycle (850°C/10min)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Double-step characterization (DC) with crystallization followed by staining
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CO) with crystallization (850°C/10min)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Repeated firings (2, 4, or 6 times)
Number of subjects: 30
Study: 35905310

Group type: EXPERIMENTAL
Intervention: CNN-based deep learning algorithm using lateral cervical spine radiographs
Number of subjects: 187
Study: 35653761

Group type: EXPERIMENTAL
Intervention: Daily skin-to-skin contact (SSC) for 1 hour daily for the first 5 weeks postpartum
Number of subjects: 116

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Daily skin-to-skin contact (SSC)
Number of subjects: 116
Study: 36494849

Group type: EXPERIMENTAL
Intervention: Endoscopic radial artery harvest
Number of subjects: 300

Group type: COMPARATOR
Intervention: Open radial artery harvest
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Aorto-radial anastomosis
Number of subjects: 300

Group type: COMPARATOR
Intervention: Mammario-radial anastomosis
Number of subjects: 300
Study: 34695804

Group type: EXPERIMENTAL
Intervention: Nudges including contextual cues (painted footpath from toilet to handwashing station) and visible reminders (posters and eye sticker)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (no nudges)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Nudges including contextual cues and visible reminders
Number of subjects: 132
Study: 33124989

Group type: EXPERIMENTAL
Intervention: KhunLook mobile app
Number of subjects: 356

Group type: COMPARATOR
Intervention: MCHH
Number of subjects: 356
Study: 616775476

Group type: EXPERIMENTAL
Intervention: Lactobacillus coryniformis CECT5711 strain as a coadjuvant in a vaccination process
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36007710

Group type: EXPERIMENTAL
Intervention: Sperm processed using microfluidics
Number of subjects: 1372

Group type: COMPARATOR
Intervention: Sperm processed using density gradient centrifugation
Number of subjects: 1372
Study: 34385241

Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg/day plus LHRHa
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Enzalutamide monotherapy
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Placebo plus LHRHa
Number of subjects: 1050
Study: 35371278

Group type: EXPERIMENTAL
Intervention: ESWT combined with wIRA therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: wIRA therapy (Control)
Number of subjects: 120
Study: 34551944

Group type: EXPERIMENTAL
Intervention: Virtual reality simulation training combined with skills training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional training of emergency response
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 34896642

Group type: EXPERIMENTAL
Intervention: Cervical length (CL) ≤30 mm
Number of subjects: 3449

Group type: EXPERIMENTAL
Intervention: Cervical length <25 mm
Number of subjects: 3449

Group type: EXPERIMENTAL
Intervention: Cervical length between 25 and 30 mm
Number of subjects: 3449
Study: 34058682

Group type: EXPERIMENTAL
Intervention: Omadacycline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moxifloxacin
Number of subjects: 0
Study: 33163127

Group type: EXPERIMENTAL
Intervention: IV oliceridine
Number of subjects: 2

Group type: COMPARATOR
Intervention: IV conventional opioids (CO cohort)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: IV oliceridine (high-risk patients)
Number of subjects: 2

Group type: COMPARATOR
Intervention: IV conventional opioids (high-risk patients)
Number of subjects: 2
Study: 35934873

Group type: EXPERIMENTAL
Intervention: Emergency umbilical button cannula (EUC) using lateral umbilical cord incision (L-EUC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emergency umbilical button cannula (EUC) using standard intersection (S-EUC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Umbilical catheter (UC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emergency umbilical button cannula (EUC)
Number of subjects: 0
Study: 32917473

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) with low-energy flux density (0.05–0.30 mJ/mm2)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 48
Study: 32605536

Group type: EXPERIMENTAL
Intervention: Daily questioning
Number of subjects: 141

Group type: COMPARATOR
Intervention: Fortnightly questioning
Number of subjects: 141

Group type: COMPARATOR
Intervention: High (3-question) question loads
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Low (1-question) question loads
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Financial incentivisation
Number of subjects: 141

Group type: COMPARATOR
Intervention: No financial incentivisation
Number of subjects: 141
Study: 35679680

Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein diet (CRHP: C30E%-P30E%-F40E%)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional diabetes diet (CD: C50E%-P17E%-F33E%)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein diet (CRHP)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional diabetes diet (CD)
Number of subjects: 72
Study: 33147430

Group type: EXPERIMENTAL
Intervention: Impella usage
Number of subjects: 885

Group type: EXPERIMENTAL
Intervention: Percutaneous ventricular assist devices
Number of subjects: 885
Study: 32545147

Group type: EXPERIMENTAL
Intervention: Moringa flour
Number of subjects: 40

Group type: COMPARATOR
Intervention: Iron group
Number of subjects: 40
Study: 34954221

Group type: EXPERIMENTAL
Intervention: Sphenopalatine ganglion block (SPGB) with 2% lidocaine prior to anaesthesia induction
Number of subjects: 52
Study: 33509762

Group type: EXPERIMENTAL
Intervention: Restrictive fluid management
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional fluid management
Number of subjects: 51
Study: 32839619

Group type: EXPERIMENTAL
Intervention: Cardiac and aortic imaging phenotypes
Number of subjects: 26893

Group type: EXPERIMENTAL
Intervention: Imaging phenotypes
Number of subjects: 26893

Group type: EXPERIMENTAL
Intervention: Population-based cardiac and aortic imaging
Number of subjects: 26893
Study: 36014837

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (100,000 IU every 4 weeks for 12 weeks)
Number of subjects: 130
Study: 32092760

Group type: EXPERIMENTAL
Intervention: rapamycin + ketamine
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo + ketamine
Number of subjects: 20
Study: 33545548

Group type: EXPERIMENTAL
Intervention: Bufei Yishen formula (BYF) combined with conventional Western medicine
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Key active molecules (KAM) of BYF
Number of subjects: 134
Study: 35150086

Group type: EXPERIMENTAL
Intervention: Vivifrail exercise intervention
Number of subjects: 188

Group type: COMPARATOR
Intervention: Usual-care control
Number of subjects: 188
Study: 33966913

Group type: COMPARATOR
Intervention: Buccal chamfer
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Lingual chamfer
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Circumferential chamfer
Number of subjects: 128
Study: 32888370

Group type: EXPERIMENTAL
Intervention: Methotrexate (15 mg weekly)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Secukinumab (standard dose)
Number of subjects: 130
Study: 36040362

Group type: EXPERIMENTAL
Intervention: 99.9% pure CBD (200 mg/day for 2 weeks, then 300 mg/day for 10 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33545577

Group type: EXPERIMENTAL
Intervention: proG-CSF
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: proG-CSF (secondary prophylaxis)
Number of subjects: 487

Group type: COMPARATOR
Intervention: Control group (no proG-CSF)
Number of subjects: 487
Study: 35657375

Group type: EXPERIMENTAL
Intervention: DrugSorb™‐AntiThrombotic Removal (ATR) haemoadsorption device
Number of subjects: 1

Group type: COMPARATOR
Intervention: Control circuit without the haemoadsorption device
Number of subjects: 1
Study: 33441010

Group type: EXPERIMENTAL
Intervention: Inoculation with 1 × 10^6/ml spore suspension of Fusarium redolens
Number of subjects: 3

Group type: COMPARATOR
Intervention: Sterile water (control)
Number of subjects: 3
Study: 35164986

Group type: EXPERIMENTAL
Intervention: FINLAY-FR-1 (50 µg d-RBD plus outer membrane vesicles from N. meningitidis)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: FINLAY-FR-1A-50 (50 µg d-RBD, three doses)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: FINLAY-FR-1A-25 (25 µg d-RDB, three doses)
Number of subjects: 60

Group type: COMPARATOR
Intervention: FINLAY-FR-1 (homologous schedule)
Number of subjects: 60

Group type: COMPARATOR
Intervention: FINLAY-FR-1 (heterologous schedule)
Number of subjects: 60
Study: 34159704

Group type: EXPERIMENTAL
Intervention: Autologous concentrated growth factors (CGF)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 50
Study: 32538747

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid parenteral nutrition
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (equal-nitrogen and equal-calorie enteral and parenteral nutrition)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 34022926

Group type: EXPERIMENTAL
Intervention: Peer support (n = 10 units)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lean implementation (n = 10 units)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sustainability (n = 10 units)
Number of subjects: 30
Study: 32504178

Group type: EXPERIMENTAL
Intervention: Quadriceps tendon–patellar bone (QTB) autograft
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bone–patellar tendon–bone (BPTB) autograft
Number of subjects: 60
Study: 616606737

Group type: EXPERIMENTAL
Intervention: Interval aerobic training (12 weeks, treadmill running at 50-80% heart rate reserve, 3 times a week, duration increased from 12 to 36 minutes)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study: 34358534

Group type: EXPERIMENTAL
Intervention: ANN-assisted model based on CT radiomics of primary tumors
Number of subjects: 313

Group type: COMPARATOR
Intervention: Traditional LN evaluation
Number of subjects: 313
Study: 32280092

Group type: EXPERIMENTAL
Intervention: Mg supplementation
Number of subjects: 250
Study: 36120764

Group type: EXPERIMENTAL
Intervention: TE + INIT
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: TE + SM
Number of subjects: 80

Group type: COMPARATOR
Intervention: TE
Number of subjects: 80
Study: 33348306

Group type: EXPERIMENTAL
Intervention: Foot reflexology for 20 minutes, done for three consecutive days.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo treatment for 20 minutes, done for three consecutive days.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 90
Study: 32825555

Group type: EXPERIMENTAL
Intervention: Interactive physical-cognitive game-based training, 1 hour session, 3 times a week for 12 weeks
Number of subjects: 40
Study: 35421086

Group type: EXPERIMENTAL
Intervention: Morning bright light therapy (10,000 lux at the eye) for 60 minutes every morning for 4 weeks
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Morning bright light therapy
Number of subjects: 33
Study: 34167430

Group type: EXPERIMENTAL
Intervention: incomplete radiofrequency ablation (iRFA)
Number of subjects: 0
Study: 33144269

Group type: EXPERIMENTAL
Intervention: QPS5
Number of subjects: 46

Group type: COMPARATOR
Intervention: cTBS
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: QPS
Number of subjects: 46

Group type: COMPARATOR
Intervention: TBS
Number of subjects: 46
Study: 33030412

Group type: EXPERIMENTAL
Intervention: 30-min bout of cycling at 50% to 60% of maximal power output
Number of subjects: 20

Group type: COMPARATOR
Intervention: Watching a neutral film
Number of subjects: 20
Study: 34086695

Group type: EXPERIMENTAL
Intervention: Dolphins image condition
Number of subjects: 20944

Group type: EXPERIMENTAL
Intervention: Ocean wildlife image condition
Number of subjects: 20944

Group type: EXPERIMENTAL
Intervention: Children image condition
Number of subjects: 20944

Group type: EXPERIMENTAL
Intervention: People staring out image condition
Number of subjects: 20944
Study: 35183882

Group type: EXPERIMENTAL
Intervention: 5 mg of boron citrate twice a day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 200 mg of oleoylethanolamide twice a day
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both therapies (5 mg of boron citrate and 200 mg of oleoylethanolamide)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine treatments without any study medications (Control)
Number of subjects: 40
Study: 34059428

Group type: EXPERIMENTAL
Intervention: Instagram advertisements (Traffic campaign + Feed ad placement)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Instagram advertisements (other strategies)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study: 35781459

Group type: EXPERIMENTAL
Intervention: Anifrolumab (Saphnelo®) administered as an intravenous infusion, 300 mg over a 30-minute period, every 4 weeks
Number of subjects: 0
Study: 32377783

Group type: EXPERIMENTAL
Intervention: 2 g TXA (intravenous)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 2 g TXA (topical)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 2 g TXA (combined intravenous + topical)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 4 g TXA (combined + group)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 35610659

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 80

Group type: COMPARATOR
Intervention: MICT
Number of subjects: 80
Study: 34781799

Group type: EXPERIMENTAL
Intervention: Point-of-sale communication campaign for cigarillos
Number of subjects: 1976

Group type: EXPERIMENTAL
Intervention: Point-of-sale communication campaign for waterpipe tobacco
Number of subjects: 1976

Group type: COMPARATOR
Intervention: No message control condition for cigarillos
Number of subjects: 1976

Group type: COMPARATOR
Intervention: No message control condition for waterpipe tobacco
Number of subjects: 1976
Study: 33148266

Group type: EXPERIMENTAL
Intervention: Health Literacy (HL)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Self-care behaviors
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Health Literacy and Self-care behaviors combined with demographic variables
Number of subjects: 192
Study: 34137514

Group type: EXPERIMENTAL
Intervention: Aomei meloxicam (15 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Mobic meloxicam (15 mg)
Number of subjects: 48
Study: 33103469

Group type: EXPERIMENTAL
Intervention: Metabolic surgery (Roux‐en‐Y gastric bypass and sleeve gastrectomy)
Number of subjects: 566

Group type: COMPARATOR
Intervention: Control group (no metabolic surgery)
Number of subjects: 566
Study: 37436823

Group type: EXPERIMENTAL
Intervention: Pictorial HWLs on the tobacco package
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Pictorial HWLs on all waterpipe's parts
Number of subjects: 403

Group type: COMPARATOR
Intervention: Text-only HWL on the tobacco package
Number of subjects: 403
Study: 33719920

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA, 20 min)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 31
Study: 33001144

Group type: EXPERIMENTAL
Intervention: Oxymetazoline, 0.1%
Number of subjects: 304

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 304
Study: 35607946

Group type: EXPERIMENTAL
Intervention: γ‐tACS (transcranial alternating current stimulation at gamma-frequency)
Number of subjects: 60

Group type: COMPARATOR
Intervention: sham tACS
Number of subjects: 60
Study: 32700572

Group type: EXPERIMENTAL
Intervention: Immediate initiation of lipid lowering (treatment for 30 years) in 40- to 49-year-old patients with non-HDL-C ≥160 mg/dL
Number of subjects: 3148

Group type: EXPERIMENTAL
Intervention: Delaying lipid lowering by 10 years (treatment for 20 years)
Number of subjects: 3148

Group type: EXPERIMENTAL
Intervention: Delaying lipid lowering by 20 years (treatment for 10 years)
Number of subjects: 3148
Study: 35733202

Group type: EXPERIMENTAL
Intervention: Bilateral motor priming and task-specific training (30 hours total over 5 weeks)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control priming (transcutaneous electrical stimulation) plus task-specific training (30 hours total over 5 weeks)
Number of subjects: 76
Study: 34094511

Group type: EXPERIMENTAL
Intervention: Higher-protein nut-based (HP-NB) snack
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Higher-protein nut-based (HP-NB) snack + white bread (WB)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Higher-carbohydrate (CHO) cereal-based bar (HC-CB)
Number of subjects: 10
Study: 32344499

Group type: EXPERIMENTAL
Intervention: LNG-IUS
Number of subjects: 203

Group type: COMPARATOR
Intervention: Cu-IUDs
Number of subjects: 203
Study: 35704027

Group type: EXPERIMENTAL
Intervention: 3.2 g/day CLA
Number of subjects: 65

Group type: COMPARATOR
Intervention: 3.2 g/day sunflower oil (placebo)
Number of subjects: 65
Study: 33106482

Group type: EXPERIMENTAL
Intervention: Spectral analysis technique for resolving time dependence in quantum processors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized benchmarking, gate set tomography, and Ramsey spectroscopy
Number of subjects: 0
Study: 32456704

Group type: EXPERIMENTAL
Intervention: Web-based Neonatal Resuscitation Game (Gamers)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Players (Gamers who utilized the game)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Non-players (Gamers who did not utilize the game)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (Controls with no access to the game)
Number of subjects: 162
Study: 32859542

Group type: EXPERIMENTAL
Intervention: Intermittent diet
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diet plus physical therapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Physical therapy
Number of subjects: 60
Study: 32996629

Group type: EXPERIMENTAL
Intervention: Refined Cue Utilization and Engagement in Dementia (CUED) mealtime video-coding scheme
Number of subjects: 110
Study: 35440469

Group type: EXPERIMENTAL
Intervention: Colchicine (500 µg daily for 14 days)
Number of subjects: 2755

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2755

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 2755
Study: 34285701

Group type: EXPERIMENTAL
Intervention: Berberis integerrima fruit extract (1000 mg daily, 5 ml twice daily)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (standard treatment with metformin only)
Number of subjects: 65
Study: 34227113

Group type: EXPERIMENTAL
Intervention: Thula Sana intervention
Number of subjects: 333
Study: 33773697

Group type: EXPERIMENTAL
Intervention: Enriched bread with 0.05% of a 1:1 mixture of (‐)‐epicatechin and quercetin
Number of subjects: 156